1986
DOI: 10.1016/0091-6749(86)90390-8
|View full text |Cite
|
Sign up to set email alerts
|

Asthma and hay fever Nonallergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
16
0

Year Published

1987
1987
2002
2002

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 0 publications
0
16
0
Order By: Relevance
“…In another Swedish study, BHR increased less during the birch pollen season in an immunotherapy-treated group than in a placebo-treated group [29]. while in contrast, a Canadian study of dustmite treated children has shown a tendency toward increased BHR in treated patients compared to a control group [30]. It is thus still doubtful whether immunotherapy affects BHR.…”
Section: Discussionmentioning
confidence: 94%
“…In another Swedish study, BHR increased less during the birch pollen season in an immunotherapy-treated group than in a placebo-treated group [29]. while in contrast, a Canadian study of dustmite treated children has shown a tendency toward increased BHR in treated patients compared to a control group [30]. It is thus still doubtful whether immunotherapy affects BHR.…”
Section: Discussionmentioning
confidence: 94%
“…Murray et al . observed an insignificant increase of BR to histamine after HDM‐SIT, while BR decreased in subjects without SIT [ 14].…”
Section: Discussionmentioning
confidence: 99%
“…In a placebocontrolled study, Van Bever et al found no significant change of BR to histamine after one year of SIT with a standardized HDM-extract [11]. Murray et al observed an insignificant increase of BR to histamine after HDM-SIT, while BR decreased in subjects without SIT [14].…”
Section: Discussionmentioning
confidence: 99%
“…The National Institutes of Health (NIH) International Consensus Report on Diagnosis and Management and the World Health Organization (WHO)/NIH Global Initiative on Asthma Management recommend that allergen immunotherapy should only be considered when asthma is poorly controlled with drugs, and where allergen avoidance is impossible [27,28]. There has been at least one report, MURRAY et al [29], which demonstrated the enhancement of nonspecific AHR by more than two-fold after mite immunotherapy in patients with atopic asthma. Although it may be premature to apply the results of the present study directly to humans, the animal model presented in this report may help to clarify why allergen immunotherapy is not always as effective as expected.…”
Section: Discussionmentioning
confidence: 99%